中医药学报
中醫藥學報
중의약학보
ACTA CHINESE MEDICINE AND PHARMACOLOGY
2014年
3期
155-157
,共3页
幽门杆菌%中药%消化性溃疡%复发
幽門桿菌%中藥%消化性潰瘍%複髮
유문간균%중약%소화성궤양%복발
Helicobacter pylori%Traditional Chinese medicine%Peptic ulcers%Recurrence
目的:探究中药佐治三联疗法治疗幽门螺杆菌相关性消化性溃疡的临床疗效。方法:62例消化性溃疡患者依照随机数字表法分为观察组和对照组。每组各31例。对照组接受雷贝拉唑,克拉霉素和阿莫西林胶囊治疗。观察组在对照组的基础上加予中药治疗。结果:对照组总有效率70.9%。观察组总有效率93.5%。两组差异明显具有统计学意义(χ2=5.41,P<0.05)。治疗后随访半年,对照组复发率为36%(8/22),观察组复发率为6.9%(2/29),两组复发率相比有明显差异(χ2=4.54,P<0.01)。结论:中药联合西药三联疗法治疗幽门螺杆菌相关性消化性溃疡的临床疗效显著,复发率低。
目的:探究中藥佐治三聯療法治療幽門螺桿菌相關性消化性潰瘍的臨床療效。方法:62例消化性潰瘍患者依照隨機數字錶法分為觀察組和對照組。每組各31例。對照組接受雷貝拉唑,剋拉黴素和阿莫西林膠囊治療。觀察組在對照組的基礎上加予中藥治療。結果:對照組總有效率70.9%。觀察組總有效率93.5%。兩組差異明顯具有統計學意義(χ2=5.41,P<0.05)。治療後隨訪半年,對照組複髮率為36%(8/22),觀察組複髮率為6.9%(2/29),兩組複髮率相比有明顯差異(χ2=4.54,P<0.01)。結論:中藥聯閤西藥三聯療法治療幽門螺桿菌相關性消化性潰瘍的臨床療效顯著,複髮率低。
목적:탐구중약좌치삼련요법치료유문라간균상관성소화성궤양적림상료효。방법:62례소화성궤양환자의조수궤수자표법분위관찰조화대조조。매조각31례。대조조접수뢰패랍서,극랍매소화아막서림효낭치료。관찰조재대조조적기출상가여중약치료。결과:대조조총유효솔70.9%。관찰조총유효솔93.5%。량조차이명현구유통계학의의(χ2=5.41,P<0.05)。치료후수방반년,대조조복발솔위36%(8/22),관찰조복발솔위6.9%(2/29),량조복발솔상비유명현차이(χ2=4.54,P<0.01)。결론:중약연합서약삼련요법치료유문라간균상관성소화성궤양적림상료효현저,복발솔저。
Objective:To investigate the clinical efficacy of traditional Chinese medicine combined with triple therapy on Helicobacter Pylori associated peptic ulcer .Methods:62 cases of peptic ulcer were divided into observation group and control group according to random number table .31 cases were in each group .The control group was received rabe-prazole, clarithromycin and amoxicillin capsules .The observation group was received traditional Chinese medicine on the basis of the therapy in the control group .Results:The total efficiency was 70.9%in the control group.In observa-tion group the total efficiency was 93 .5%.There was a significant difference in two groups (χ2 =5 .41 ,P<0 .05 ) .Dur-ing follow-up of six months, the recurrence rate in control group was 36%(8/22).The recurrence rate was 6.9%in the observation group (2/29), The results had significant differences after treatment (χ2 =4.54,P<0.01).Conclu-sion:Traditional Chinese medicine combined with triple therapy has a better clinical efficacy and lower recurrence rate .